Cardiovascular disease is the leading cause of death in women in most developed countries. Surveys have repeatedly found that a substantial share of women don’t know this, and often identify breast cancer as the greater threat.
The gap between actual risk and perceived risk has consequences for how seriously symptoms are taken — by women themselves, and by the clinicians they see.
Where the misperception comes from
Heart disease has a long-standing cultural association with middle-aged men. That image was reinforced by decades of research conducted predominantly in male populations.
Women were historically underrepresented in cardiovascular clinical trials, for reasons ranging from concerns about pregnancy to assumptions that findings would generalize. The consequence is that much of the foundational evidence base describes disease as it presents in men, and that description became the default.
Representation in trials has improved. The accumulated understanding built on the earlier evidence has been slower to update.
Presentation differs
The classic description of a heart attack — crushing central chest pain radiating to the left arm — does occur in women. Chest discomfort is the most common presenting symptom in women as it is in men.
But women more frequently present with additional or alternative symptoms:
- Shortness of breath
- Nausea or vomiting
- Pain in the jaw, neck, back, or between the shoulder blades
- Unusual fatigue, sometimes preceding the event by days
- Lightheadedness
- Discomfort described as pressure, tightness, or fullness rather than pain
These are less specific. They resemble many benign things. That ambiguity contributes to delay — women tend to wait longer before seeking care, and are somewhat more likely to be initially misattributed to non-cardiac causes.
Any of these symptoms, particularly appearing together or with exertion, warrants immediate evaluation. Delay is the modifiable part of this problem.
Different underlying patterns
Beyond symptoms, some disease mechanisms occur with different frequency.
Coronary microvascular dysfunction involves impairment of the heart’s smallest vessels rather than blockage of major arteries. It’s more commonly identified in women, and standard angiography — which visualizes larger vessels — may appear normal. A woman with real symptoms can be told her arteries are clear while microvascular disease goes unaddressed.
Spontaneous coronary artery dissection (SCAD), a tear in a coronary artery wall, disproportionately affects women, including younger women without conventional risk factors.
Takotsubo cardiomyopathy, sometimes called stress cardiomyopathy, occurs predominantly in women, most often postmenopausal.
Plaque erosion rather than rupture appears more common in women as a mechanism of acute events.
Risk factors that are female-specific or weighted differently
Pregnancy complications carry long-term cardiovascular significance. Preeclampsia, gestational hypertension, gestational diabetes, and preterm delivery are all associated with elevated later cardiovascular risk. Pregnancy has been described as a stress test that reveals underlying predisposition — but these events are frequently absent from cardiovascular risk assessment years later, if they’re asked about at all.
Early menopause, whether natural or surgical, is associated with increased cardiovascular risk.
Polycystic ovary syndrome, associated with insulin resistance and metabolic risk factors.
Autoimmune conditions including rheumatoid arthritis and lupus, which are more prevalent in women and carry elevated cardiovascular risk.
Diabetes, which appears to confer a greater relative increase in cardiovascular risk in women than in men.
Smoking, likewise associated with a stronger relative risk increase in women.
Several of these — pregnancy history in particular — are not captured by widely-used risk calculators, which means the calculated risk can understate the actual picture.
What’s worth doing
Know your numbers. Blood pressure, lipids, glucose. Cardiovascular risk factors are as relevant for women as for men.
Make sure your pregnancy history is on the record. If you had preeclampsia, gestational hypertension, or gestational diabetes, that belongs in your cardiovascular risk assessment permanently — not only in your obstetric notes. Raise it if it isn’t asked about.
Take the menopause transition seriously as a cardiovascular inflection point. Lipids often shift, and risk changes.
Take symptoms seriously. Persistent unusual fatigue, breathlessness on exertion that’s new, or discomfort in the chest, jaw, or upper back deserve evaluation. The tendency to minimize is well documented and is the part most within your control.
Advocate. If symptoms are dismissed and you remain concerned, seeking another opinion is reasonable. That shouldn’t be necessary, and sometimes it is.
The underlying issue here isn’t that the medicine doesn’t exist. It’s that a body of knowledge built primarily on one population has been slow to fully accommodate the other — and the correction is still working its way through practice.
Understanding where you stand today is the first step. A comprehensive assessment looks at these markers together, in the context of your history and your goals.
This article is general education from the Nextgenlongevityhealth clinical team. It is not medical advice, does not establish a provider–patient relationship, and is not a substitute for evaluation by a licensed clinician who knows your history. If you are experiencing a medical emergency, call your local emergency number.